Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 12—December 2022
CME ACTIVITY - Synopsis

Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019

Florence Hoefler1Comments to Author , Xavier Pouget-Abadie, Mariam Roncato-Saberan, Romain Lemarié, Eve-Marie Takoudju, François Raffi, Stéphane Corvec, Morgane Le Bras2, Charles Cazanave, Philippe Lehours, Thomas Guimard, and Caroline Allix-Béguec
Author affiliations: Centre Hospitalier La Rochelle, La Rochelle, France (F. Hoefler, X. Pouget-Abadie, M. Roncato-Saberan, R. Lemarié, C. Allix-Béguec); Centre Hospitalier Départemental Vendée, La Roche sur Yon, France (E.-M. Takoudju, T. Guimard); Centre Hospitalier Universitaire de Nantes, Nantes, France (F. Raffi, S. Corvec, M. Le Bras); Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France (C. Cazanave, P. Lehours)

Main Article

Table 3

Clinical characteristics and outcome of patients with and without septic shock after acute Vibrio infection, Bay of Biscay, France, 2001–2019*

Characteristic
 No sepsis, n = 42
 Septic shock, n = 13
 p value
No. % (95% CI) No. % (95% CI)
Patient sex
M 35 83 (72–95) 10 77 (54–100) 0.685
F
 7
 17 (5–28)
3
 23 (0.2–46)
Underlying conditions
Heart failure 18 43 (28–58) 6 46 (19–73) Referent
Neoplasia 6 14 (4–25) 4 31 (6–56) 0.223
Diabetes 7 17 (5–28) 1 8 (0–22) 0.664
Kidney failure 5 12 (2–22) 2 15 (0–35) 0.664
Immune disease 5 12 (2–22) 2 15 (0–35) 0.664
Hemopathy 3 7 (0–15) 2 15 (0–35) 0.582
Liver disease 2 5 (0–11) 3 23 (0–46) 0.318
Alcohol use disorder 3 7 (0–15) 4 31 (6–56) 0.102
Preexisting wound 6 14 (4–25) 0 0 (0–0) 0.317
Digestive surgery
 4
 10 (1–18)
2
 15 (0–35)
 0.618
Species
V. alginolyticus 10 24 (11–37) 4 31 (6–56)
V. parahaemolyticus 14 33 (19–48) 5 38 (12–65)
V. cholerae non-O1/O139 8 19 (7–31) 2 15 (0–35)
V. vulnificus 6 14 (4–25) 1 8 (0–22)
Other Vibrio species
 4
 10 (1–18)
1
 8 (0–22)
Outcome
Recovered 40 95 (89–100) 7 54 (27–81) 0.001
Died
 2 5 (0–11) 6 46 (19–73)

*Median patient age (+SD) was 60 (+21.4) for no sepsis and 61 (+15.3) for septic shock.

Main Article

1Current affiliation: Centre Hospitalier Troyes, Troyes, France.

2Current affiliation: Centre Hospitalier d’Auxerre, Auxerre, France.

Page created: November 21, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external